| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATER | Common Stock | Sale | -$165K | -5.21K | -2.01% | $31.66* | 255K | 10 Mar 2021 | Direct | F1, F2 |
| transaction | ATER | Common Stock | Sale | -$21.1K | -636 | -0.25% | $33.13* | 254K | 10 Mar 2021 | Direct | F1, F3 |
| transaction | ATER | Common Stock | Sale | -$121K | -3.56K | -1.4% | $33.96* | 250K | 10 Mar 2021 | Direct | F1, F4 |
| transaction | ATER | Common Stock | Sale | -$82.7K | -2.35K | -0.94% | $35.13* | 248K | 10 Mar 2021 | Direct | F1, F5 |
| transaction | ATER | Common Stock | Sale | -$149K | -4.12K | -1.66% | $36.16* | 244K | 10 Mar 2021 | Direct | F1, F6 |
| transaction | ATER | Common Stock | Sale | -$110K | -2.97K | -1.22% | $37.16* | 241K | 10 Mar 2021 | Direct | F1, F7 |
| transaction | ATER | Common Stock | Sale | -$24.2K | -638 | -0.26% | $37.97* | 240K | 10 Mar 2021 | Direct | F1, F8 |
| transaction | ATER | Common Stock | Options Exercise | $2.74M | +282K | +117.36% | $9.72* | 522K | 11 Mar 2021 | Direct | F9 |
| transaction | ATER | Common Stock | Sale | -$8.11M | -255K | -48.79% | $31.81* | 268K | 11 Mar 2021 | Direct | F1, F10 |
| transaction | ATER | Common Stock | Sale | -$431K | -13.1K | -4.9% | $32.90* | 254K | 11 Mar 2021 | Direct | F1, F11 |
| transaction | ATER | Common Stock | Sale | -$218K | -6.44K | -2.53% | $33.80* | 248K | 11 Mar 2021 | Direct | F1, F12 |
| transaction | ATER | Common Stock | Sale | -$286K | -8.25K | -3.33% | $34.60* | 240K | 11 Mar 2021 | Direct | F1, F13, F14 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ATER | Employee Stock Option (right to buy) | Options Exercise | $0 | -282K | -100% | $0.00* | 0 | 11 Mar 2021 | Common Stock | 282K | $9.72 | Direct | F9, F15 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. |
| F2 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.51 to $32.45, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.62 to $33.60, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.63 to $34.63, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.64 to $35.63, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.69 to $36.68, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.71 to $37.71, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to $38.16, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F9 | The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. |
| F10 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.445 to $32.445, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F11 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.45 to $33.45, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F12 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.53 to $34.52, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F13 | The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.60 to $34.7399, inclusive. The holder undertakes to provide to the issuer, any security holder of the issuer, or staff of the Securities Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F14 | 776,315 shares held of record by the Sarig-Bulow Family Trust previously reported as indirect ownership by the Reporting Person are not being reported on this Form 4 and will not be reported on future Form 4's by the Reporting Person because the Reporting Person does not beneficially own such shares pursuant to the arrangements of the Trust. |
| F15 | Pursuant to the initial terms of the option, 1/3rd of the number of shares subject to the option vested on October 11, 2019 and 1/36th of the number of shares subject to the option would vest following each one month period thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The Issuer accelerated the vesting of 60,000 shares subject to the option to March 11, 2021. |
President and Chief Executive Officer This Form 4 is being amended and restated to correct the sales transactions that were previously reported, including correcting the date on which the sales occurred and the prices at which such sales occurred, and to correct the number of securities beneficially owned following the reported transactions.